Please login to the form below

Not currently logged in
Email:
Password:

ABT-530

This page shows the latest ABT-530 news and features for those working in and with pharma, biotech and healthcare.

AbbVie hepatitis C combo shows high cure rates

AbbVie hepatitis C combo shows high cure rates

The new phase II data on NS3/4A protease inhibitor ABT-493 and NS5A inhibitor ABT-530 - which recently started pivotal trials - showed that 97-98% of patients with genotype ... AbbVie is hoping to be able to show that ABT-493/ABT-530 can achieve high

Latest news

  • AbbVie takes 'one-size-fits-all' HCV regimen into phase III AbbVie takes 'one-size-fits-all' HCV regimen into phase III

    The co-formulated drug - which combines NS3/4A protease inhibitor ABT-493 with NS5A inhibitor ABT-530 - will be tested in six phase III trials involving patients with HCV genotypes

  • Hepatitis C therapies: dawn of a new age Hepatitis C therapies: dawn of a new age

    AbbVie is developing a DAA-based, IFN-free regimen centred on the protease inhibitor ABT 450. ... AbbVie is co-formulating its next-generation compounds ABT 530 and ABT 493, its ritonavir-free protease inhibitor, and Gilead has GS 5816 poised for phase 3

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics